1. Home
  2. LXRX vs ETX Comparison

LXRX vs ETX Comparison

Compare LXRX & ETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ETX
  • Stock Information
  • Founded
  • LXRX 1995
  • ETX 2005
  • Country
  • LXRX United States
  • ETX United States
  • Employees
  • LXRX N/A
  • ETX N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ETX
  • Sector
  • LXRX Health Care
  • ETX
  • Exchange
  • LXRX Nasdaq
  • ETX NYSE
  • Market Cap
  • LXRX 228.8M
  • ETX 196.9M
  • IPO Year
  • LXRX 2000
  • ETX N/A
  • Fundamental
  • Price
  • LXRX $0.63
  • ETX $18.15
  • Analyst Decision
  • LXRX Buy
  • ETX
  • Analyst Count
  • LXRX 4
  • ETX 0
  • Target Price
  • LXRX $3.67
  • ETX N/A
  • AVG Volume (30 Days)
  • LXRX 4.1M
  • ETX 32.7K
  • Earning Date
  • LXRX 05-13-2025
  • ETX 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • ETX 4.20%
  • EPS Growth
  • LXRX N/A
  • ETX N/A
  • EPS
  • LXRX N/A
  • ETX N/A
  • Revenue
  • LXRX $31,213,000.00
  • ETX N/A
  • Revenue This Year
  • LXRX N/A
  • ETX N/A
  • Revenue Next Year
  • LXRX $46.60
  • ETX N/A
  • P/E Ratio
  • LXRX N/A
  • ETX N/A
  • Revenue Growth
  • LXRX 1251.21
  • ETX N/A
  • 52 Week Low
  • LXRX $0.28
  • ETX $16.36
  • 52 Week High
  • LXRX $2.45
  • ETX $18.60
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 51.48
  • ETX 53.85
  • Support Level
  • LXRX $0.62
  • ETX $18.12
  • Resistance Level
  • LXRX $0.72
  • ETX $18.46
  • Average True Range (ATR)
  • LXRX 0.05
  • ETX 0.15
  • MACD
  • LXRX -0.00
  • ETX 0.00
  • Stochastic Oscillator
  • LXRX 59.81
  • ETX 53.49

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About ETX EATON VANCE MUNICIPAL INCOME 2028

Eaton Vance Municipal Income 2028 Term Trust is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The fund invests in various sectors such as a bond bank, education, housing, electric utilities, transportation, and others.

Share on Social Networks: